{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:51:00Z","timestamp":1760921460763,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Education, Science and Technology (MEST), Republic of Korea","award":["2017R1D1A1B03032168"],"award-info":[{"award-number":["2017R1D1A1B03032168"]}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI15C2483"],"award-info":[{"award-number":["HI15C2483"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cyto.2018.01.010","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T14:38:54Z","timestamp":1517495934000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Frequencies of IL-15R\u03b1+ cells in patients with Beh\u00e7et\u2019s disease and the effects of overexpressing IL-15R\u03b1+ on disease symptoms in mice"],"prefix":"10.1016","volume":"110","author":[{"given":"S.M. Shamsul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunsoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-So","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonghyang","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.01.010_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-7-20","article-title":"Behcet's disease","volume":"7","author":"Saadoun","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.cyto.2018.01.010_b0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.imbio.2013.03.005","article-title":"Therapeutic potency of Poly I: C in HSV-induced inflammation through up-regulation of IL-15 receptor alpha","volume":"218","author":"Choi","year":"2013","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.cyto.2018.01.010_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02505221","article-title":"Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease","volume":"288","author":"Lee","year":"1996","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1099\/00222615-34-1-39","article-title":"Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction","volume":"34","author":"Studd","year":"1991","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0025","first-page":"21","article-title":"Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice","volume":"8","author":"Sohn","year":"1998","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3349\/ymj.1988.29.1.72","article-title":"Behcet's syndrome in Korea: a look at the clinical picture","volume":"29","author":"Kim","year":"1988","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.cyto.2018.01.010_b0035","first-page":"638273","article-title":"Immunopathogenic role of Herpes simplex virus in Behcet's disease","volume":"2013","author":"Kim","year":"2013","journal-title":"Genet. Res. Int."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.01.010_b0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.156.2.735","article-title":"Induction and regulation of IL-15 expression in murine macrophages","volume":"156","author":"Doherty","year":"1996","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.cyto.2018.01.010_b0050","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1002\/j.1460-2075.1995.tb00035.x","article-title":"Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor","volume":"14","author":"Giri","year":"1995","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.cyto.2018.01.010_b0055","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.158.6.2610","article-title":"Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells","volume":"158","author":"Jonuleit","year":"1997","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2018.01.010_b0060","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cyto.2018.01.010_b0065","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI118321","article-title":"Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro","volume":"96","author":"Carson","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.cyto.2018.01.010_b0070","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00296-013-2705-4","article-title":"The distinct expressions of interleukin-15 and interleukin-15 receptor alpha in Behcet's disease","volume":"33","author":"Choe","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2018.01.010_b0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08830189809042995","article-title":"Interleukin-2, interleukin-15, and their receptors","volume":"16","author":"Waldmann","year":"1998","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.01.010_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imlet.2009.09.009","article-title":"Trans-presentation: a novel mechanism regulating IL-15 delivery and responses","volume":"127","author":"Stonier","year":"2010","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","article-title":"Interleukin-15 biology and its therapeutic implications in cancer","volume":"33","author":"Steel","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2018.01.010_b0090","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.1500300","article-title":"IL-15 superagonist-mediated immunotoxicity: role of NK cells and IFN-gamma","volume":"195","author":"Guo","year":"2015","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2018.01.010_b0095","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.170.10.5018","article-title":"IL-15 promotes the survival of naive and memory phenotype CD8+ T cells","volume":"170","author":"Berard","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.01.010_b0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.0610115104","article-title":"The IL-15\/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells","volume":"104","author":"Sato","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cyto.2018.01.010_b0105","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.173.9.5818","article-title":"Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15\/Fc protein prevents disease development and progression in murine collagen-induced arthritis","volume":"173","author":"Ferrari-Lacraz","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2018.01.010_b0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Behcet uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.cyto.2018.01.010_b0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/aid.2010.0317","article-title":"Expression of interleukin-15 and interleukin-15Ralpha in monocytes of HIV type 1-infected patients with different courses of disease progression","volume":"28","author":"Tarkowski","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cyto.2018.01.010_b0120","first-page":"85","article-title":"IL-15 agonists: the cancer cure cytokine","volume":"7","author":"Wu","year":"2013","journal-title":"J. Mol. Genet. Med."},{"issue":"8697","key":"10.1016\/j.cyto.2018.01.010_b0125","first-page":"1078","article-title":"International study group for Behcet's disease","volume":"335","author":"Criteria for diagnosis of Behcet's disease","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","article-title":"Serum cytokine profiles in Behcet's disease: is there a role for IL-15 in pathogenesis?","volume":"121","author":"Curnow","year":"2008","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.cyto.2018.01.010_b0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-3083.2006.01844.x","article-title":"Levels of IL-15 in serum and cerebrospinal fluid of patients with Behcet's disease","volume":"64","author":"Hamzaoui","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2018.01.010_b0140","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.177.9.6072","article-title":"Combined IL-15\/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo","volume":"177","author":"Stoklasek","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2018.01.010_b0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/14653249.2011.571245","article-title":"CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model","volume":"13","author":"Shim","year":"2011","journal-title":"Cytotherapy"},{"issue":"22","key":"10.1016\/j.cyto.2018.01.010_b0150","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"Chiossone","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cyto.2018.01.010_b0155","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ibd.20457","article-title":"Efficacy of infliximab for induction and maintenance of remission in intestinal Behcet's disease","volume":"14","author":"Naganuma","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"1\u20133","key":"10.1016\/j.cyto.2018.01.010_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2008.09.005","article-title":"Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model","volume":"598","author":"Bang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2018.01.010_b0165","doi-asserted-by":"crossref","first-page":"10888","DOI":"10.1038\/ncomms10888","article-title":"IL-15-dependent balance between Foxp3 and RORgammat expression impacts inflammatory bowel disease","volume":"7","author":"Tosiek","year":"2016","journal-title":"Nature Commun."},{"issue":"5","key":"10.1016\/j.cyto.2018.01.010_b0170","first-page":"639","article-title":"Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease","volume":"21","author":"Gonzalez-Alvaro","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2018.01.010_b0175","first-page":"2389","article-title":"Serum levels of interleukin 15 in patients with rheumatic diseases","volume":"28","author":"Suzuki","year":"2001","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2018.01.010_b0180","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/kei083","article-title":"IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus","volume":"44","author":"Baranda","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imm.12014","article-title":"Interleukin-15 receptor alpha expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab","volume":"138","author":"Perrier","year":"2013","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2016.06.055","article-title":"IL-15 up-regulates the MMP-9 expression levels and induces inflammatory infiltration of macrophages in polymyositis through regulating the NF-kB pathway","volume":"591","author":"Yan","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.cyto.2018.01.010_b0195","first-page":"e1177","article-title":"Crohn's disease and ulcerative colitis show unique cytokine profiles","volume":"9","author":"Nemeth","year":"2017","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.cyto.2018.01.010_b0200","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00296-013-2868-z","article-title":"Interleukin-15 and its receptor (IL-15Ralpha) serve as new therapeutic implications for Behcet's disease","volume":"34","author":"He","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.cyto.2018.01.010_b0205","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1053\/j.gastro.2010.02.044","article-title":"Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease","volume":"138","author":"Bouchaud","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cyto.2018.01.010_b0210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","article-title":"Epidermal IL-15Ralpha acts as an endogenous antagonist of psoriasiform inflammation in mouse and man","volume":"210","author":"Bouchaud","year":"2013","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2018.01.010_b0215","doi-asserted-by":"crossref","first-page":"e59009","DOI":"10.1371\/journal.pone.0059009","article-title":"Increased expression of IL-22 is associated with disease activity in Behcet's disease","volume":"8","author":"Cai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.01.010_b0220","first-page":"1425","article-title":"Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery","volume":"17","author":"Jiang","year":"2011","journal-title":"Mol. Vis."},{"issue":"3 Suppl 77","key":"10.1016\/j.cyto.2018.01.010_b0225","first-page":"32","article-title":"Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity","volume":"31","author":"Na","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","article-title":"Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease","volume":"30","author":"Oztas","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.cyto.2018.01.010_b0235","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22- and TNF-alpha-producing Th22 cells in uveitis patients with Behcet's disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.01.010_b0240","doi-asserted-by":"crossref","unstructured":"B. Choi, H.M. Sayeed, S.M.S. Islam, S. Sohn, Role of N-acetyl galactosamine-4-SO4, a ligand of CD206 in HSV-induced mouse model of Behcet's disease, Eur. J. Pharmacol. (2017).","DOI":"10.1016\/j.ejphar.2017.07.022"},{"issue":"3","key":"10.1016\/j.cyto.2018.01.010_b0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/gt.2008.180","article-title":"Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet's disease-like mouse model","volume":"16","author":"Shim","year":"2009","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.cyto.2018.01.010_b0250","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.0906-6705.2004.00210.x","article-title":"Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behcet's disease-like mouse model","volume":"13","author":"Sohn","year":"2004","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2018.01.010_b0255","doi-asserted-by":"crossref","first-page":"e90960","DOI":"10.1371\/journal.pone.0090960","article-title":"Interleukin-15 and soluble interleukin-15 receptor alpha in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution","volume":"9","author":"Dozio","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.01.010_b0260","doi-asserted-by":"crossref","unstructured":"A.C. Machado Diaz, A. Chico Capote, C.A. Arrieta Aguero, Y. Rodriguez Alvarez, D. Garcia Del Barco Herrera, M. Estevez Del Toro, G.E. Guillen Nieto, A. Santos Savio, Proinflammatory soluble interleukin-15 receptor alpha is increased in rheumatoid arthritis, Arthritis 2012 (2012) 943156.","DOI":"10.1155\/2012\/943156"},{"issue":"12","key":"10.1016\/j.cyto.2018.01.010_b0265","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.1700046","article-title":"Cutting edge: differential fine-tuning of IL-2- and IL-15-dependent functions by targeting their common IL-2\/15Rbeta\/gammac receptor","volume":"198","author":"Meghnem","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.01.010_b0270","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4049\/jimmunol.166.2.885","article-title":"Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain","volume":"166","author":"Joshi","year":"2001","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2018.01.010_b0275","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.imbio.2015.07.004","article-title":"IL-2\/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model","volume":"220","author":"Choi","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cyto.2018.01.010_b0280","first-page":"861920","article-title":"Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy","volume":"2011","author":"Meazza","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.cyto.2018.01.010_b0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4049\/jimmunol.181.1.225","article-title":"A function for IL-7R for CD4+ CD25+ Foxp3+ T regulatory cells","volume":"181","author":"Bayer","year":"2008","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2018.01.010_b0290","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood-2002-11-3392","article-title":"IL-15 is an essential mediator of peripheral NK-cell homeostasis","volume":"101","author":"Ranson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2018.01.010_b0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.01.010_b0300","doi-asserted-by":"crossref","first-page":"19699","DOI":"10.1038\/srep19699","article-title":"High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner","volume":"6","author":"Polansky","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cyto.2018.01.010_b0305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/acel.12291","article-title":"The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15\/IL-15Ralpha treatment","volume":"14","author":"Nair","year":"2015","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.cyto.2018.01.010_b0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10067-006-0312-4","article-title":"Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis","volume":"26","author":"Kageyama","year":"2007","journal-title":"Clin. Rheumatol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618300103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618300103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:53:01Z","timestamp":1760907181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618300103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":62,"alternative-id":["S1043466618300103"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.01.010","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequencies of IL-15R\u03b1+ cells in patients with Beh\u00e7et\u2019s disease and the effects of overexpressing IL-15R\u03b1+ on disease symptoms in mice","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}